Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad.
The Zostavax® vaccine is now available nationally for immunisation providers for people aged 70 to 79 years under the National Immunisation Program (NIP).
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice regarding alternatives during supply shortage of the adult formulations of hepatitis B vaccines.
The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice for immunisation providers regarding the administration of 2018 seasonal influenza vaccines.
Coverage rates amongst Australian children continue to improve with 5 year old children having the highest coverage rates in history. 94% of Australian 5 year olds and over 96% of Aboriginal and Torres Strait Islander 5 year olds are now fully vaccinated.
Australia's medicine and medical devices regulator, the Therapeutic Goods Administration (TGA), has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
A national immunisation coverage target provides a goal against which Australia can measure its immunisation coverage. The Global Vaccine Action Plan 2011-2020 encourages countries to demonstrate a commitment to immunisation.
The Department has developed a template which provides a checklist for immunisation providers to consider before vaccinating a patient with Zostavax (pre-vaccination checklist).
From early 2018, young Australians have free access to the new human papillomavirus (HPV) vaccine, Gardasil®9 that protects against more types of HPV infection.
The Australian Government will invest $3 million under the Medical Research Future Fund to advance stem cell research projects for kids.
The South Australian Academic Health Science and Translation Centre will receive funding under the Medical Research Future Fund to deliver new ground breaking medical research projects.
Australian competitors for the Invictus Games Sydney 2018 (IG2018) are in their final stages of preparation. There are just 100 days to go until the opening ceremony on 20 October 2018. Let the countdown begin!
More than $12 million is being provided to two research translation centres through the Medical Research Future Fund to help tackle some of Australia’s big health challenges.
The Australian Medical Research Advisory Board will be seeking comment, through online submissions and public forums in July and August.
The Australian Technical Advisory Group on Immunisation (ATAGI) has new advice to support school based immunisation providers with the introduction of Gardasil®9 in a 2-dose schedule from January 2018.
A $100 million research fund set up by the Government aims to double survival rates for brain cancer over the next ten years, with the ultimate goal of one day defeating brain cancer.
The 2018–19 Budget includes a $1.3 billion Health and Medical Industry Growth plan to drive a new era of better health care while fuelling jobs and growth in new firms and industries through research.